Es-Is Technologies
Enzymatic Solutions for Drug Synthesis
Company Overview
Snapshot
Founded in January 2010 by Ehud Wizer, Es-Is Technologies operates with 1-10 employees. The company focuses on developing enzyme-catalyzed processes for pharmaceutical ingredient production.
Business overview
Es-Is Technologies leverages computational power to develop enzyme-catalyzed processes for the rapid and cost-effective synthesis of pharmaceutical ingredients. The company designs novel, enzyme-based syntheses using advanced computer algorithms and atomic-level biomolecule understanding, aiming to create cost-effective, non-infringing, and patentable synthetic chemicals. Es-Is collaborates with leading pharmaceutical companies to integrate clean chemo-enzymatic processes into drug production, serving the pharmaceutical and life sciences industries in markets such as India, Spain, Europe, and China.
Company Intelligence Q&A
- What is Es-Is Technologies' core product?
- Es-Is Technologies develops EnzyMatrix, a product focused on enzymatic solutions for drug synthesis.
- What is the primary focus of Es-Is Technologies?
- Es-Is Technologies focuses on harnessing computing power to develop enzyme-catalyzed processes for faster and more cost-effective production of pharmaceutical ingredients.
- Which markets does Es-Is Technologies target?
- Es-Is Technologies targets geomarkets including India, Spain, Europe, and China.
- Who is a key founder of Es-Is Technologies?
- Ehud Wizer is a Co-Founder and CEO of Es-Is Technologies.
- What is the company's approach to chemical synthesis?
- Es-Is Technologies designs enzymes for the creation of synthetic chemicals through cost-effective, non-infringing, and patentable processes, utilizing advanced computer algorithms and biomolecular understanding.